Autoantibodies against myelin oligodendrocyte glycoprotein (MOG) occur in a proportion of patients with different inflammatory demyelinating diseases of the central nervous system, such as childhood multiple sclerosis (MS), acute disseminated encephalomyelitis (ADEM), and neuromyelitis optica spectrum disorders (NMOSD). We describe here in detail a sensitive cell-based assay that allows the identification of autoantibodies against MOG in serum.
CITATION STYLE
Spadaro, M., & Meinl, E. (2015). Detection of autoantibodies against myelin oligodendrocyte glycoprotein in multiple sclerosis and related diseases. Methods in Molecular Biology, 1304, 99–104. https://doi.org/10.1007/7651_2015_223
Mendeley helps you to discover research relevant for your work.